Personal Genomics takes PacBio dispute to Chinese court
22-05-2020
Illumina buys rival Pacific Biosciences for $1.2bn
02-11-2018
Vchal / Shutterstock.com
In its suit, filed at the US District Court for the District of Delaware on Thursday, September 26, PGI accused Pacific Biosciences of infringing US patent 7,767,441 through the sale of its nucleic acid sequencing platform Sequel System.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Pacific Biosciences, genetics, genetic sequencing, Personal Genomics Taiwan, patent infringement, illumina, gene-sequencing
